Physician

Adeel Khan, M.D.

According to 2025 Medicare claims, Adeel Khan, M.D. (NPI: 1467481465) practices nephrology in the Midland, MI market, with the plurality of this provider's patient population coming from Midland, MI. This provider's primary affiliated billing organization is RENAL ASSOCIATES OF MID-MICHIGAN PC (NPI: 1194911941; TIN: 208162674) and primary practice location at 48640-2905. Khan is affiliated with the POM ACO (ACO ID: A1297), participating under the MSSP model.

Khan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 459 traditional Medicare patients, billed 1,871 HCPCS/CPT codes, and received $266,633 in Medicare payments. The top billing code was 90961 (Dialysis services, 2-3 physician visits per month (20 years or older)). Part D data shows 2,238 prescription claims across 462 beneficiaries totaling $289,614 in drug costs, led by Xphozah (Tenapanor Hcl). DME data shows 28 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $802,615 to $289,614. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $2,042 to $333.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$352K$705K2015 Medicare payment: $387,769 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $377,844 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $367,118 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $386,710 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $704,665 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $369,159 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $381,565 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $393,786 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $315,715 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $266,633 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,1113,777$387,769
20161,0943,702$377,844
20171,0313,484$367,118
20181,0143,530$386,710
20191,3886,598$704,665
20208353,204$369,159
20217922,729$381,565
20227864,151$393,786
20234292,219$315,715
20244591,871$266,633

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$406K$812K2015 Drug cost: $802,615 (USD; Tot_Drug_Cst)2016 Drug cost: $811,937 (USD; Tot_Drug_Cst)2017 Drug cost: $668,544 (USD; Tot_Drug_Cst)2018 Drug cost: $367,156 (USD; Tot_Drug_Cst)2019 Drug cost: $337,482 (USD; Tot_Drug_Cst)2020 Drug cost: $227,835 (USD; Tot_Drug_Cst)2021 Drug cost: $231,907 (USD; Tot_Drug_Cst)2022 Drug cost: $223,885 (USD; Tot_Drug_Cst)2023 Drug cost: $280,098 (USD; Tot_Drug_Cst)2024 Drug cost: $289,614 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20156745,580$802,615
20165914,739$811,937
20175264,347$668,544
20185443,702$367,156
20195983,846$337,482
20204752,896$227,835
20214662,665$231,907
20224382,294$223,885
20234652,075$280,098
20244622,238$289,614

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$15K$29K2015 Medicare payment: $29,065 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $12,468 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $19,111 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $25,242 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $14,413 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $4,583 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $2,428 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $895 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $1,551 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $344 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201511332$29,065
2016N/R163$12,468
2017N/R273$19,111
201811431$25,242
2019N/R298$14,413
2020N/R188$4,583
2021N/R138$2,428
2022N/R72$895
2023N/R96$1,551
2024N/R28$344

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
90961Dialysis services, 2-3 physician visits per month (20 years or older)94461$211
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more7171$110
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more227356$56
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes61212$56
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more5666$51

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XphozahTenapanor Hcl15630$57,911
FarxigaDapagliflozin Propanediol312,100$38,489
JardianceEmpagliflozin281,440$27,649
EliquisApixaban141,080$20,233
Sevelamer CarbonateSevelamer Carbonate543,120$17,750

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R15$176
J7517Mycophenolate mofetil, oral, 250 mgNN/R13$168

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Adeel Khan, M.D.?

Tedicare shows public-source Medicare data for Adeel Khan, M.D. (NPI 1467481465), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adeel Khan, M.D. have ACO affiliation data?

Adeel Khan, M.D. is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297).

What billing organization is linked to Adeel Khan, M.D.?

Adeel Khan, M.D. is linked to RENAL ASSOCIATES OF MID-MICHIGAN PC (billing NPI 1194911941) in the available physician profile data.

Does Adeel Khan, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.